HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Madhu Khanna, Speaker at Immunology Conferences
Keynote Presentation (In-person)
Madhu Khanna, University of Delhi, India

Influenza viruses continue to cause severe emerging and remerging outbreaks worldwide. Recent viral pandemics of the 2009 [pandemic influenza A (H1N1)] and 2019 (SARS-CoV-2), have enhanced the need of vigilance for combating such emerging and re-emerging viral outbreaks and mitig [....] » Read More

Ayesha Zahid, Speaker at Veterinary Vaccine Conferences
Oral Presentation (In-person)
Ayesha Zahid, Griffith University, Australia

Background: Middle ear infection (otitis media) remains the most common childhood disease diagnosed among Australian Indigenous children. Despite extensive antibiotic usage, it persists as a significant health concern, characterized by substantial morbidity and economic burden. S [....] » Read More

Yousfi Tarek, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria

A series of new isoxazolidine and pyrazolidine compounds were synthesized in very good yields of 76-99.2% by Michael and Aza-Michael reactions, respectively, and all compounds were characterized by 1H NMR, 13C NMR. we discovered that the pyrrolidine/benzoic acid catalyzed in Mich [....] » Read More

Anifrid Thomson Mahenge, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Anifrid Thomson Mahenge, NIMR-Mbeya Medical Research Center, Tanzania, United Republic of

Background: Currently it is not clear whether co-infection with other sexually transmitted infections (STIs) may promote HPV persistence and progression of cervical lesions to CC. We explore the quality of self-cytobrush in HPV detection and associations with STIs in young Tanzan [....] » Read More

Negar Seyed, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)

Leishmaniasis (a sandfly0borne disease) is caused by the unicellular parasite from Leishmania genus and is already a major thread in tropical and subtropical regions of the world but the distribution map could shift to other regions due to climate change. Unfortunately, no vaccin [....] » Read More

Ashley Prout, Speaker at Vaccines Congress
Oral Presentation (In-person)
Ashley Prout, Merck, United States

Gardasil® and Gardasil®9 are multivalent recombinant vaccines consisting of adjuvanted virus-like particles (VLP) assembled from monomers of the main structural protein (L1) of the human papilloma virus (HPV) expressed in Saccharomyces cerevisiae yeast. The critical quali [....] » Read More

Swarandeep Singh, Speaker at Immunology Conferences
Poster Presentation (In-person)
Swarandeep Singh, All India Institute of Medical Sciences, India

Induction of broadly neutralizing antibodies (bNAbs) is a major goal in HIV-1 vaccine research. Elite neutralizers are rare HIV-1-infected individuals who develop broad and potent neutralizing antibody responses. Herein, we characterize a stabilized HIV-1 Clade-C envelope mimic, [....] » Read More

Awranoos Ahadi, Speaker at Immunology Conferences
Poster Presentation (In-person)
Awranoos Ahadi, Bolan Medical College, Pakistan

Background: The Eastern Mediterranean Region (EMRO) of the World Health Organization (WHO) is the last region in which polio transmission continues. Afghanistan and Pakistan, also being parts of South Asia, pose a major burden for the transmission of the virus both in the EMRO an [....] » Read More

Attahir Abubakar, Speaker at Vaccines meetings
Poster Presentation (In-person)
Attahir Abubakar, Ahmadu Bello University, Nigeria

This study examines the awareness and acceptability of the rotavirus vaccine among mothers of children under five in Gusau and Bungudu, Zamfara State, Nigeria. Employing a comparative cross-sectional design, the research utilized quantitative surveys and qualitative focus groups [....] » Read More

Temesgen Azemeraw Yitayew, Speaker at Vaccine Research Conference
Poster Presentation (In-person)
Temesgen Azemeraw Yitayew, Addis Ababa University, Ethiopia

Primary HPV testing and triage of HPV – positive women is an effective cervical cancer screening strategy. Such a multi-visit screening algorithm is also promising for community based screening in resource-poor communities, provided a robust tracking system is in place.&nbs [....] » Read More

Elena Chiappini, Speaker at Immunology Conferences
Oral Presentation (Virtual)
Elena Chiappini, University of Florence, Italy

Background: Paediatric tuberculosis (TB) represents a critical health concern due to the significant risk of extrapulmonary TB (EPTB), severe disease forms, and the increasing prevalence of drug-resistant strains (DR-TB). Understanding the clinical characteristics of affected chi [....] » Read More

Ahmed Abdulazeez, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Ahmed Abdulazeez, BHRUT Trust, United Kingdom

This study aims to review the available data regarding the central role of immunity in combating SARS-CoV-2 infection and in the generation of protection by vaccination against COVID-19 in different age groups. Physiologically, the immune response and the components involved in i [....] » Read More

Livia Daflon Silva, Speaker at Cancer Vaccines Congress
Oral Presentation (Virtual)
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil

Introduction: In Brazil, the 10-valent and 23-valent pneumococcal vaccines are available free of charge and are the most common pneumococcal vaccines administered. These vaccines play a key role in preventing severe bacterial infections caused by Streptococcus pneumoniae. However [....] » Read More

K R Aneja, Speaker at Immunotherapy Conferences
Oral Presentation (Virtual)
K R Aneja, Kurukshetra University, India

The incidence of fungal infections, called mycosis, has dramatically increased in COVID-19 patients with predisposing factors. COVID-19, not over and still circulating worldwide, is a respiratory illness caused by strains of coronavirus SARS-CoV-2 (severe acute respiratory syndro [....] » Read More

Yacob Mathai, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Yacob Mathai, Marma Health Centre, India

If the body becomes inflamed after consuming a substance, our immune system tells us that the substance is against the body.  If the substance further increases inflammation, reduces blood flow, and affects organ function, the substance is life-threatening.  Vaccinat [....] » Read More

Manuel Antonio Sierra Santos, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Manuel Antonio Sierra Santos, Central American Technological University, Honduras

Background/Introduction: COVID-19’s pandemic has had a catastrophic global impact, with nearly one billion reported infections and seven million deaths worldwide. By the middle 2020, several studies described the so-called long COVID syndrome as an emerging and prevalent s [....] » Read More

Nathalia Lucas da Silva Andrade, Speaker at Vaccines Congress
Poster Presentation (Virtual)
Nathalia Lucas da Silva Andrade, Universidad Nacional de Cordoba, Argentina

Outer Membrane Vesicles (OMV) is an innovative vaccine technology against bacterial infections. The OMVs are proposed as a vaccine platform for the presence of outer membrane proteins that act as antigens and PAMPs. Silver and gold nanoparticles provide a robust immune system res [....] » Read More

Watsapp